Skip to main content

Table 5 Motor-evoked potential at different time points (mean ± SD)

From: Effects of Dexmedetomidine on motor- and somatosensory-evoked potentials in patients with thoracic spinal cord tumor: a randomized controlled trial

Group

Measurement

T1

T2

T3

T4

Propofol group (n = 25)

ULA (uv)

280 ± 148

307 ± 147

326 ± 154

326 ± 169

ULL (ms)

20.7 ± 3.2

21.3 ± 2.2

21.6 ± 2.4

21.9 ± 2.3

URA (uv)

323 ± 139

307 ± 138

366 ± 164

343 ± 145

URL (ms)

21.2 ± 3.6

22.2 ± 4.0

21.8 ± 2.7

21.6 ± 3.5

LLA (uv)

152 ± 84

177 ± 82

208 ± 141

221 ± 113

LLL (ms)

38.9 ± 4.8

40.1 ± 5.7

40.2 ± 6.9

39.4 ± 6.6

LRA (uv)

127 ± 91

121 ± 84

140 ± 90

131 ± 105

LRL (ms)

39.0 ± 9.9

39.4 ± 10.6

40.4 ± 11.1

39.6 ± 4.2

DP adjusted group (n = 23)

ULA (uv)

293 ± 131

341 ± 207

313 ± 155

313 ± 178

ULL (ms)

20.8 ± 2.1

21.8 ± 3.6

21.3 ± 3.6

20.9 ± 2.8

URA (uv)

256 ± 137

302 ± 193

303 ± 158

339 ± 206

URL (ms)

21.1 ± 2.6

20.6 ± 2.8

20.9 ± 3.0

21.5 ± 3.3

LLA (uv)

174 ± 135

185 ± 129

179 ± 106

153 ± 78

LLL (ms)

39.4 ± 5.2

39.5 ± 3.6

39.2 ± 3.2

37.3 ± 9.9

LRA (uv)

154 ± 77

173 ± 153

187 ± 137

160 ± 98

LRL (ms)

40.5 ± 3.9

40.6 ± 4.1

40.8 ± 5.0

41.3 ± 5.3

DP unadjusted group (n = 23)

ULA (uv)

354 ± 179

353 ± 116

343 ± 153

355 ± 158

ULL (ms)

21.4 ± 2.3

21.3 ± 2.4

22.1 ± 4.0

23.1 ± 3.8

URA (uv)

354 ± 161

351 ± 191

316 ± 197

292 ± 163

URL (ms)

21.6 ± 2.6

21.7 ± 3.0

22.4 ± 4.0

23.1 ± 4.1

LLA (uv)

171 ± 114

196 ± 171

215 ± 178

169 ± 144

LLL (ms)

41.2 ± 4.4

40.0 ± 4.2

39.8 ± 3.5

39.9 ± 3.6

LRA (uv)

206 ± 153

207 ± 192

225 ± 177

199 ± 138

LRL (ms)

38.4 ± 10.7

39.8 ± 4.2

40.7 ± 4.7

38.2 ± 10.0

  1. ULA amplitude of left upper limb, ULL latency of left upper limb, URA amplitude of right upper limb, URL latency of right upper limb, LLA amplitude of left lower limb, LLL latency of left lower limb, LRA amplitude of right lower limb, LRL latency of right lower limb
  2. P: Comparison with propofol group